Stay updated with breaking news from Diffusion Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Get Rating) was the target of a significant increase in short interest in May. As of May 15th, there was short interest totalling 9,700 shares, an increase of 148.7% from the April 30th total of 3,900 shares. Approximately 0.5% of the shares of the company are sold short. Based on […]
Raven Jaeger, M.S. named Chief Regulatory Officer and Andrew Cunningham, M.D., MRCPI, named Senior Vice President, Clinical DevelopmentLA JOLLA, Calif., May 23, 2023 -- CalciMedica Inc. , a... | May 23, 2023
StockNews.com assumed coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a research report sent to investors on Sunday. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Price Performance Shares of Diffusion Pharmaceuticals stock traded up $0.14 on Friday, hitting $4.13. The stock had a trading volume of 7,272 shares, […]
StockNews.com assumed coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a research note issued to investors on Saturday morning. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Down 2.2 % Shares of DFFN stock opened at $3.97 on Friday. The business has a 50 day moving average of […]
StockNews.com assumed coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a research report sent to investors on Saturday morning. The firm issued a hold rating on the stock. Diffusion Pharmaceuticals Price Performance Shares of DFFN opened at $3.97 on Friday. The firm has a market cap of $8.10 million, a PE ratio […]